Therefore, despite extensive data indicating a pivotal role for the JAK/STAT pathway and the extensive crosstalk with other signaling axes in cancer, targeting components of the JAK/STAT pathway has yet to provide expected results. This evidence concerns the gene SOAT1 and cancer.